logo
Plus   Neg
Share
Email

GE Healthcare Launches COVID-19 Patient Data Monitoring Technology

GE Healthcare said it will deploy remote patient data monitoring technology to help clinicians support most critical covid-19 patients across the health system.

The company has introduced a new software solution-- Mural Virtual Care Solution-- to Microsoft Azure cloud platform. The software is designed to give hospitals a broad view across their ventilated patient population and help identify patients at risk of deterioration.

GE is waiving Mural software subscription charges until January 31, 2021.

The new monitoring technology will enable clinical surveillance of intensive care unit (ICU) patients - including those on mechanical ventilation - in a central place, giving a comprehensive view of each patient's data across the hospital network.
The Remote surveillance may also reduce clinicians' exposure to COVID-19, while maintaining a broad view of patients across the hospital.

In addition to real-time remote management, Mural also enables health systems to activate care protocols relevant to treating COVID-19 patients and help caregivers ensure those protocols are being followed.

The company said Mural can also help identify patients needing intervention. This includes ventilation and lung injury management for patients on extended mechanical ventilation support.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
Follow RTT